Intake of tomato-enriched diet protects from 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons

Journal of Neural Transmission, Supplementa

Volumn , Issue 73, 2009, Pages 333-341

  Di Matteo, Vincenzo ^a   Pierucci, Massimo ^a   Di Giovanni, Giuseppe ^b   Dragani, Luana Katia ^a   Murzilli, Stefania ^a   Poggi, Andreina ^a   Esposito, Ennio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

carotene; Diet; Dopamine; Lycopene; Parkinson's disease; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; BETA CAROTENE; DOPAMINE; LYCOPENE; OXIDOPAMINE; CAROTENOID; ISOMERASE; LYCOPENE CYCLASE ISOMERASE; LYCOPENE CYCLASE-ISOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATMOSPHERIC PRESSURE; CONTROLLED STUDY; DIETARY INTAKE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STRIATE CORTEX; SUBSTANTIA NIGRA; TOMATO; VITAMIN BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMISTRY; DISEASE MODEL; FISCHER 344 RAT; GENETICS; HEMISPHERIC DOMINANCE; METABOLISM; NERVE DEGENERATION; PATHOLOGY; TRANSGENIC PLANT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CAROTENOIDS; DISEASE MODELS, ANIMAL; DOPAMINE; FUNCTIONAL LATERALITY; INTRAMOLECULAR LYASES; LYCOPERSICON ESCULENTUM; MALE; NERVE DEGENERATION; OXIDOPAMINE; PARKINSON DISEASE; PLANTS, GENETICALLY MODIFIED; RATS; RATS, INBRED F344; SUBSTANTIA NIGRA;

EID: 77952299186     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-92660-4-28     Document Type: Article

References (51)

1. Al-Babili S, Beyer P (2005) Golden Rice-five years on the road-five years to go? Trends Plant Sci 10:565-73
2. Barak Y, Wohl Y, Greenberg Y, Bar Dayan Y, Friedman T, Shoval G, Knobler HY (2005) Affective psychosis following Accutane (isotretinoin) treatment. Int Clin Psychopharmacol 20:39-41
3. Blum D, Torch S, Lambeng N, Nissou M-F, Benabid A-L, Sadoul R, Verna J-M (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65:135-172
4. Bremner JD, McCaffey P (2008) The neurobiology of retinoic acid in affective disorders. Prog NeuroPsychopharmacol Biol Psychiatry 32:315-331
5. Brooks DJ (1998) The early diagnosis of Parkinson's disease. Ann Neurol 44 (Suppl): S19-S31
6. Carta M, Stancapiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F (2006) Vitamin A deficiency induces motor impairements and striatal cholinergic dysfunction in rats. Neuroscience 139:1163-1172
7. D'Ambrosio C, Giorio G, Marino I, Merendino A, Petrozza A, Salfi L, Stilliani AL, Cellini F (2004) Virtually complete conversion of lycopene into b-carotene in fruits of tomato plants transformed with the tomato lycopene b-cyclase (tlcy-b) cDNA. Plant Science 166:207-214
8. Dawson TM, Dawson VL (2002) Neuroprotective and neurorestorative strategies for Parkinson's disease. Nat Neurosci: S1058-S1061
9. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells SE, Jenner P, Marsden C (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114:1953-1975
10. Dexter DT, Holley AE, Flitter WD, Slater TF, Wells FR, Daniel S, Lees AJ, Marsden CD (1994) Increased levels of lipid hydroperoxides in the Parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord 9:92-97
11. Di Giovanni G (2008) Will it be possible to prevent nigral neurodegeneration? CNS Neurol Disord Drug Targets 7:28-44
12. Di Matteo V, Pierucci M, Di Giovanni G, Di Santo A, Poggi A, Benigno A, Esposito E (2006a) Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study. Brain Res 1095:167-177
13. Di Matteo V, Benigno A, Pierucci M, Giuliano DA, Crescimanno G, Esposito E, Di Giovanni G (2006b) 7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study. Ann NY Acad Sci 1089:462-471
14. Ebadi M, Srinivasan SK, Baxi MD (1996) Oxidative stress and antioxidant therapy in Parkinson's disease. Progr Neurobiol 48:1-19
15. Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S (2002) A review of specific antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging 23:719-735
16. Esposito E, Capasso M, di Tomasso N, Corona C, Pellegrini F, Uncini A, Vitaglione P, Fogliano V, Piantelli M, Sensi SL (2007) Antioxidant strategies based on tomato-enriched food or pyruvate do not affect disease onset and survival in an animal model of amyotrophic lateral sclerosis. Brain Res 1168:90-96
17. Fahn S (1991) An open trial of high-dosage antioxidants in early Parkinson's disease. Am J Clin Nutr 53:380S-382S
18. Fall PA, Fredrikson M, Axelson O, Granérus AK (1999) Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 14:28-37
19. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: SNc regional selectivity. Brain 114:2283-2301
20. Ferguson SA, Cisneros FJ, Gough BJ, Ali SF (2005) Four weeks of oral isotretinoin treatment causes few signs of general toxicity in male and female Sprague-Dawley rats. Food Chem Toxicol 43:1289-1296
21. Ferreira AL, Yeum K-J, Liu C, Smith D et al (2000) Tissue distribution of lycopene in ferrets and rats after lycopene supplementation. J Nutr 130:1256-60
22. Goodman AB (1998) Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA 95:7240-7244
23. Goodman DS, Huang HS (1965) Biosynthesis of vitamin A with rat intestinal enzymes. Science 149:879-880
24. Halliwell B, Gutteridge JMC (1985) Oxygen radicals and the nervous system. Trends Neurosci 6:22-26
25. Hsiao G, Fong TH, Tzu NH, Lin KH, Chou DS, Sheu JR (2004) A potent antioxidant, lycopene, affords neuroprotection against microglia activation and focal cerebral ischemia in rats. In Vivo 18:351-356
26. Jellinger K (1989) Pathology of Parkinson's disease. In: Calne DB (ed) Handbook of experimental pharmacology, vol 8. Springer, Berlin, pp 47-112
27. Jenner P, Dexter DT, Sian J, Schapira AHV, Marsden CD (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incident Lewy body disease. Ann Neurol 32:582-587
28. Krezel W, Ghyselinck N, Samad TA, Dupé V, Kastner P, Borrelli E, Chambon P (1998) Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279:863-867
29. Lang AE, Lozan AM (1998) Parkinson's disease first of two parts. New Engl J Med 339:1044-1053
30. Mabrouk OS, Roth BL, Sivagnaniar I, Pehek EA (2003) Vitamin A derivative 13-cis retinoic acid (Accutane) modulates stress induced dopamine release in the rat medial prefrontal cortex. Society for Neuroscience Abstracts (2003 Abstract Viewer/Itinerary Planner), 461. 14
31. Mattson MP, Chan SL, Duan W (2002) Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 82:637-672
32. Nagao A (2004) Oxidative conversion of carotenoids to retinoids and other products. J Nutr 134:273S-240S
33. Nguyen ML, Schwartz SJ (1998) Lycopene stability during food processing. Proc Soc Exp Biol Med 218:101-105
34. Olson JA, Hayaisshi O (1965) The enzymatic cleavage of b-carotene into vitamin A by soluble enzymes of rat liver and intestine. Proc Natl Acad Sci USA 54:1364-1370
35. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, New York
36. Perry TL, Yong VW, Hansen S, Jones K, Bergeron C, Foulks JG, Wright JM (1987) a-Tocopherol and b-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J Neurol Sci 81:321-331
37. Rao AV, Agarwal S (2000) Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr 19:563-569
38. Rao AV, Balachandran B (2002) Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 5:291-309
39. Rao AV (2004) Processed tomato products as a source of dietary lycopene: bioavailability and antioxidant properties. Can J Diet Pract Res 65:161-165
40. Ribaya-Mercado JD, Holmgren SC, Fox JG, Russell RM (1989) Dietary b-carotene absorption and metabolism in ferrets and rats. J Nutr 119:665-668
41. Riso P, Visioli F, Erba D, Testolin G, Porrini M (2004) Lycopene and vitamin C concentrations increase in plasma and lymphocytes after tomato intake. Effect on cellular antioxidant protection. Eur J Clin Nutr 58:1350-1358
42. Rissanen TH, Voutilainen S, Nyyssonen K, Lakka TA, Sivenius J, Salonen R, Kaplan GA, Salonen JT (2001) Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Hearth Disease Risk Factor Study. Br J Nutr 85:749-754
43. Saga Y, Kobayashi M, Ohta H, Murai N, Nakai N, Oshima M, Taketo MM (1999) Impaired extrapyramidal function caused by the targeted disruption of retinoid receptor RXRγ1 isoform. Genes Cells 4:219-228
44. Samad TA, Krezel W, Chambon P, Borrelli E (1997) Regulation of dopaminergic pathway by retinoids: Activation of D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci USA 94:14349-14354
45. Scherman D, Desnos C, Darchen F, Pollak P, Javoy-Agid F, Agid Y (1989) Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol 26:551-557
46. Simonian NA, Coyle JT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36:83-106
47. Suganuma H, Hirano T, Arimoto Y, Inakuma T (2002) Effect of tomato intake on striatal monoamine level in a mouse model of experimental Parkinson's disease. J Nutr Sci Vitaminol 48:251-254
48. Talalay P (2000) Chemoprotection against cancer by induction of phase 2 enzyme. Biofactors 12:5-11
49. Veldink JH, Kalmijn S, Groeneveld GJ, Wunderink W, Koster A, de Vries JH, van der Luyt J, Wokke JH, Van den Berg LH (2007) Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 78:367-371
50. von Bohlen und Halbach O, Schober A, Krieglstein K (2004) Genes, proteins, and neurotoxins involved in Parkinson's disease. Prog Neurobiol 73:151-177
51. Zetterström RH, Lindqvist E, de Urquiza AM, Tomac A, Eriksson U, Perlmann T, Olson L (1999) Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 11:407-416